Department of Otolaryngology - Head and Neck Surgery, University of Alabama at Birmingham, 1720 Second Avenue South, Birmingham, AL, 35294, USA.
Curr Allergy Asthma Rep. 2020 May 19;20(7):20. doi: 10.1007/s11882-020-00916-6.
Chronic rhinosinusitis (CRS) is a heterogenous disease process affecting a significant proportion of the population and impacting quality of life and productivity. Historically, CRS has been classified broadly into CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). Increased understanding regarding unique presentations of CRS subsets and their underlying inflammatory profiles has led to a new system for classifying CRS phenotypes.
Consideration of CRS phenotypes has traditionally been a key factor in determining treatment paradigms. Under a new phenotype classification system, physical findings will continue to drive treatment decisions, but with more precision. Recent rapidly accumulated knowledge indicates that the broad categorization of CRSwNP or CRSsNP is no longer clinically useful. Reorganization of CRS phenotypes and their underlying endotypes will lead to more targeted and efficacious therapy.
慢性鼻-鼻窦炎(CRS)是一种异质性疾病过程,影响着相当一部分人群,并影响生活质量和生产力。历史上,CRS 被广泛分为伴有鼻息肉的 CRS(CRSwNP)和不伴有鼻息肉的 CRS(CRSsNP)。对 CRS 亚组的独特表现及其潜在炎症特征的深入了解,导致了 CRS 表型分类的新系统。
CRS 表型的考虑一直是确定治疗方案的关键因素。在新的表型分类系统下,体格检查结果将继续驱动治疗决策,但更具准确性。最近迅速积累的知识表明,CRSwNP 或 CRSsNP 的广泛分类在临床上不再有用。CRS 表型及其潜在的内型的重新组织将导致更有针对性和更有效的治疗。